# A Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients

> **NCT07484633** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Semmelweis University** · enrollment: 110 (estimated)

## Conditions studied

- Infection
- Sepsis
- NICU
- PICU
- Beta Lactams

## Interventions

- **DRUG:** Extended infusion time of the following beta-lactam: meropenem
- **DRUG:** Short-term infusion time of the following beta-lactam: meropenem
- **DRUG:** Extended infusion time of the following beta-lactam: piperacillin/tazobactam
- **DRUG:** Extended infusion time of the following beta-lactam: cefepime
- **DRUG:** Extended infusion time of the following beta-lactam: ceftriaxone
- **DRUG:** Short-term infusion time of the following beta-lactam: piperacillin/tazobactam
- **DRUG:** Short-term infusion time of the following beta-lactam: cefepime
- **DRUG:** Short-term infusion time of the following beta-lactam: ceftriaxone

## Key facts

- **NCT ID:** NCT07484633
- **Lead sponsor:** Semmelweis University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-04
- **Final completion:** 2028-04
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07484633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07484633, "A Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07484633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*